Literature DB >> 23937567

Quantitative variation in plasma angiotensin-I converting enzyme activity shows allelic heterogeneity in the ABO blood group locus.

Chikashi Terao1, Nervana Bayoumi, Colin A McKenzie, Diana Zelenika, Shigeo Muro, Michiaki Mishima, John M C Connell, Mark A Vickers, G Mark Lathrop, Martin Farrall, Fumihiko Matsuda, Bernard D Keavney.   

Abstract

Angiotensin-I converting enzyme (ACE) occupies a pivotal role in cardiovascular homeostasis. Major loci for plasma ACE have been identified at ACE on Chromosome 17 and at ABO on Chromosome 9. We sought to characterise the genetic architecture of plasma ACE at finer resolution in two populations. We carried out a GWAS in 1810 individuals of Japanese ethnicity; this identified signals at ACE and ABO that together accounted for nearly half of the population variability of the trait. We conducted measured haplotype analysis at the ABO locus in 1425 members of 248 British families using haplotypes of three SNPs, which together tagged the alleles responsible for the principal blood group antigens A1, A2, B and O. Type O alleles were associated with intermediate plasma ACE activity compared to Type A1 alleles (in whom plasma ACE activity was ∼36% lower) and Type B alleles (in whom plasma ACE activity was ∼36% higher). We demonstrated heterogeneity among A alleles: A2 alleles were associated with plasma ACE activity that was very similar to the O alleles. Variation at ACE accounted for 35% of the trait variance, and variation at ABO accounted for 15%. A further 10% could be ascribed to polygenic effects.
© 2013 John Wiley & Sons Ltd/University College London.

Entities:  

Keywords:  ABO blood group; QTL; angiotensin‐I converting enzyme; genome wide association study

Mesh:

Substances:

Year:  2013        PMID: 23937567     DOI: 10.1111/ahg.12034

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


  9 in total

Review 1.  p53/NF-kB Balance in SARS-CoV-2 Infection: From OMICs, Genomics and Pharmacogenomics Insights to Tailored Therapeutic Perspectives (COVIDomics).

Authors:  Daniela Milani; Lorenzo Caruso; Enrico Zauli; Adi Mohammed Al Owaifeer; Paola Secchiero; Giorgio Zauli; Donato Gemmati; Veronica Tisato
Journal:  Front Pharmacol       Date:  2022-05-27       Impact factor: 5.988

2.  A genome-wide association study identifies variants in KCNIP4 associated with ACE inhibitor-induced cough.

Authors:  J D Mosley; C M Shaffer; S L Van Driest; P E Weeke; Q S Wells; J H Karnes; D R Velez Edwards; W-Q Wei; P L Teixeira; L Bastarache; D C Crawford; R Li; T A Manolio; E P Bottinger; C A McCarty; J G Linneman; M H Brilliant; J A Pacheco; W Thompson; R L Chisholm; G P Jarvik; D R Crosslin; D S Carrell; E Baldwin; J Ralston; E B Larson; J Grafton; A Scrol; H Jouni; I J Kullo; G Tromp; K M Borthwick; H Kuivaniemi; D J Carey; M D Ritchie; Y Bradford; S S Verma; C G Chute; A Veluchamy; M K Siddiqui; C N A Palmer; A Doney; S H MahmoudPour; A H Maitland-van der Zee; A D Morris; J C Denny; D M Roden
Journal:  Pharmacogenomics J       Date:  2015-07-14       Impact factor: 3.550

3.  COVID-19 and Individual Genetic Susceptibility/Receptivity: Role of ACE1/ACE2 Genes, Immunity, Inflammation and Coagulation. Might the Double X-chromosome in Females Be Protective against SARS-CoV-2 Compared to the Single X-Chromosome in Males?

Authors:  Donato Gemmati; Barbara Bramanti; Maria Luisa Serino; Paola Secchiero; Giorgio Zauli; Veronica Tisato
Journal:  Int J Mol Sci       Date:  2020-05-14       Impact factor: 5.923

4.  The association between ABO blood group and SARS-CoV-2 infection: A meta-analysis.

Authors:  Davide Golinelli; Erik Boetto; Elisa Maietti; Maria Pia Fantini
Journal:  PLoS One       Date:  2020-09-18       Impact factor: 3.240

5.  The rs8176740 T/A and rs512770 T/C Genetic Variants of the ABO Gene Increased the Risk of COVID-19, as well as the Plasma Concentration Platelets.

Authors:  Gilberto Vargas-Alarcón; Julian Ramírez-Bello; Rosalinda Posadas-Sánchez; Gustavo Rojas-Velasco; Alberto López-Reyes; Laura Martínez-Gómez; Silvestre Ortega-Peña; Isela Montúfar-Robles; Rosa Elda Barbosa-Cobos; Marva Arellano-González; José Manuel Fragoso
Journal:  Biomolecules       Date:  2022-03-23

6.  Regional genetic differences among Japanese populations and performance of genotype imputation using whole-genome reference panel of the Tohoku Medical Megabank Project.

Authors:  Jun Yasuda; Fumiki Katsuoka; Inaho Danjoh; Yosuke Kawai; Kaname Kojima; Masao Nagasaki; Sakae Saito; Yumi Yamaguchi-Kabata; Shu Tadaka; Ikuko N Motoike; Kazuki Kumada; Mika Sakurai-Yageta; Osamu Tanabe; Nobuo Fuse; Gen Tamiya; Koichiro Higasa; Fumihiko Matsuda; Nobufumi Yasuda; Motoki Iwasaki; Makoto Sasaki; Atsushi Shimizu; Kengo Kinoshita; Masayuki Yamamoto
Journal:  BMC Genomics       Date:  2018-07-24       Impact factor: 3.969

7.  Genetic Hypothesis and Pharmacogenetics Side of Renin-Angiotensin-System in COVID-19.

Authors:  Donato Gemmati; Veronica Tisato
Journal:  Genes (Basel)       Date:  2020-09-03       Impact factor: 4.096

Review 8.  Aβ degradation or cerebral perfusion? Divergent effects of multifunctional enzymes.

Authors:  J Scott Miners; Jennifer C Palmer; Hannah Tayler; Laura E Palmer; Emma Ashby; Patrick G Kehoe; Seth Love
Journal:  Front Aging Neurosci       Date:  2014-09-11       Impact factor: 5.750

9.  Anti-A isohaemagglutinin titres and SARS-CoV-2 neutralization: implications for children and convalescent plasma selection.

Authors:  Daniele Focosi
Journal:  Br J Haematol       Date:  2020-07-08       Impact factor: 8.615

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.